Who
Gary S. Gillheeney
President and CEO
Company insider
Files Form 4 as: President and CEO, Organogenesis Holdings.
In numbers
- Trades disclosed
- 131
- Buys
- 0
- Sells
- 29
- Bought
- $0
- Sold
- $18.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Dec 2018
- Last trade
- 18 Feb 2026
- Last filed
- 3 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —188,856 at $0.00 | filing |
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $351K91,311 at $3.84 | filing |
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —188,856 at $0.00 | filing |
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $351K91,311 at $3.84 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —890,625 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —186,968 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $347K90,398 at $3.84 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —507,795 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —507,795 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —890,625 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —186,968 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $347K90,398 at $3.84 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $91K24,340 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $293K78,646 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $309K82,815 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $319K85,605 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $91K24,340 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $293K78,646 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $309K82,815 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $319K85,605 at $3.73 | filing |
News
No headline names them, or the companies they trade most, lately.